Biohaven's ALS drug fails to meet study goals

Biohaven's ALS drug fails to meet study goals

Source: 
Yahoo/Reuters
snippet: 

Biohaven Pharmaceutical Holding Company Ltd said on Thursday its experimental drug to treat amyotrophic lateral sclerosis (ALS) failed a clinical study, the second therapy by the drugmaker to fail trials in recent months.